Global Competitiveness in the Pharmaceutical Industry: The Effect of National Regulatory, Economic, and Market Factors
Examine the global pharmaceutical industry and the effect of national, regulatory, economic, and market environments on the competitiveness of the industry!This unique book is the only empirical study that examines the effects of the national environment on the competitiveness of a country's pharmaceutical industry. This informative book explores such topics as the types of comparative advantages that firms use for developing competitive advantages and what strategic choices firms should make when collaborating with international firms. Public policy implications with respect to the economic environment are also discussed to give you a complete look at the international pharmaceutical industry. Global Competitiveness in the Pharmaceutical Industry recognizes pharmaceutical industries as being of great social and public importance to all countries, since so many life saving drugs have emerged from pharmaceutical laboratories over the past four decades. By helping to combat many fatal diseases and eradicate others, drug producers have helped to positively alter mortality patterns in many parts of the world, thus making companies compete to provide many important medicines. The unique research presented in this book examines the determinants of global competitive advantage in the pharmaceutical industry by answering such questions as:
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
031 Global Innovation approval APPTIME BBFI BBNFI CFI comparative advantage competitive advantage developing countries df p-value BBFI drugs Economic Env effect Fit Indices Chi-square foreign investment Foreign Mkt Invst frginvst gblsales TABLE global competitiveness Global Diffusion Model Global Innovation Model Global Innovation v6,v5 global pharmaceutical industry hypothesized Incoming Foreign Invst INDCONC INDFOCUS INDGRWTH industrialized countries Industrialized Developing v3,v1 industry focus INNOVAT Innovation Invst v4,v2 Innovation Model Paths ISBN Japan maceutical market/industry Mkt Invst v6,v4 Mkt/lnd Structure v3,v2 MKTPOT MKTSIZE Model Paths Overall multinationals Oligopoly Overall Industrialized Developing p-value BBFI BBNFI patent Paths Overall Industrialized percent pharma pharmaceutical innovation pharmaceutical market price control PRICEREG product liability R&D expenditures R&DEXPD relationship Sales Fit Indices Scrip standard error standardized coefficient strategic management Structural Equation Modeling t-value v1 U.S. dollars United Kingdom USITC v2=apptime v2=pricereg v3,v2 Regulation v4,v1 Economic Env v5,v4 Market v6,v4 Market Potential v6=innovat v7=gblsales
Page 177 - TOTAL (If paying in Canadian funds, Exp. Date convert using the current exchange rate, UNESCO Signature coupons welcome) Prices in US dollars and subject to change without notice. NAME INSTITUTION, ADDRESS CITY STATE/ZIP COUNTRY COUNTY (NY residents only)_ TEL FAX E-MAIL May we use your e-mail address for confirmations and other types of information?
Page 177 - SUBTOTAL D PAYMENT ENCLOSED: $ IN CANADA: ADD 7% GST D PLEASE CHARGE TO MY CREDIT CARD. STATE TAX D Visa D MasterCard D AmEx D Discover (NY, OH & MN residents, please O Diner's Club add appropriate local sales tax) Account # FINAL TOTAL (If paying in Canadian funds, Exp.